XF50X08
Destruction Liver to New Technology Group 8 with Ultrasound-guided Cavitation, External Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | X New Technology |
| Body System | F Hepatobiliary System and Pancreas |
| Operation | 5 Destruction |
| Body Part | 0 Liver |
| Approach | X External |
| Device | 0 Ultrasound-guided Cavitation |
| Qualifier | 8 New Technology Group 8 |
Operation Definition
Physical eradication of all or a portion of a body part by the direct use of energy, force, or a destructive agent
Procedure Overview
This family covers eradicating diseased tissue in the liver, bile ducts, or pancreas using an energy-based method rather than surgical removal. A notable example is irreversible electroporation, a technique that delivers short high-voltage electrical pulses through needle electrodes placed around a tumor to disrupt cell membranes and cause cell death, without relying on heat or cold the way older ablation methods do.
This approach is considered for tumors, often in the pancreas, that sit close to major blood vessels or bile ducts where heat-based ablation or surgical resection would carry too much risk of injuring those structures. It is typically performed with imaging guidance, either during an open or laparoscopic procedure or percutaneously through the skin.
Anatomy & Axis Detail
Liver
The liver as a whole organ, spanning both the right and left lobes, is targeted for destruction using new-technology energy-based systems, most notably histotripsy, which uses focused ultrasound to mechanically liquefy tissue without incisions or thermal injury to surrounding structures. This nonresectional approach is applied when a lesion or diseased tissue cannot be clearly localized to a single lobe, or when the treatment plan involves ablating multiple foci distributed across the organ. The liver's dual blood supply from the hepatic artery and portal vein, along with its regenerative capacity, allows destruction of targeted tissue while sparing enough functional parenchyma for recovery. Documentation should specify whether the treated tissue is confined to one lobe or genuinely distributed across the whole liver, since separate codes exist for right and left lobe destruction when the procedure is lobe-specific.
Approach: External
External approach in New Technology applies to procedures performed directly on the skin, mucous membranes, or via direct visualization without penetrating a body cavity, such as applying or activating a device against the body surface. It contrasts with Percutaneous approaches, which require instrument entry through the skin rather than surface-level contact.
Device / Substance / Technology: Ultrasound-guided Cavitation
This value describes a noninvasive technique that uses focused ultrasound to generate cavitation, a mechanical process of microbubble formation and collapse that disrupts targeted tissue without incisions, notably applied to liver tumor ablation. It is distinguished from thermal ablation energies by its mechanical, non-thermal mechanism of tissue destruction. Ultrasound imaging guides real-time targeting throughout the procedure.
Qualifier: New Technology Group 8
Group 8 identifies technologies added to the New Technology section for the 2021-2022 update cycle, tying a given code to that specific approval year. The underlying substance, device, or technique is defined by the other six axis positions, not by the group number itself. Because group numbers simply track chronology, Group 8 differs from Group 7 and Group 9 only in when CMS granted the technology separate recognition.
Coding & Documentation
The operative report should identify the specific organ and lesion treated, the electroporation or other energy-based system used, and confirm that the tissue was destroyed in place rather than excised, since Destruction requires that no tissue be removed from the body. Documentation of imaging guidance and electrode or probe placement supports the approach and device values. A recurring error is coding this as a resection or excision when only tissue destruction occurred, or missing the new-technology device code when the physician's note refers to the treatment by brand or technique name rather than by its ICD-10-PCS terminology.
Commonly Confused With
This family is easily confused with Excision or Resection procedures on the same organs, but those involve physically removing tissue, while Destruction eradicates it in place. It also differs from other ablation techniques such as radiofrequency or microwave ablation, which use heat, and from cryoablation, which uses cold, whereas the electroporation approach relies on electrical pulses without a significant thermal effect.